Rhumbline Advisers Clovis Oncology, Inc. Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 11, 2022	SELL	$0.63 - $2.96 $71,986 - $338,224	-114,265 Closed	0 $0
Q1 2022 May 12, 2022	BUY	$1.43 - $3.14 $1,984 - $4,358	1,388 Added 1.23%	114,265 $231,000
Q4 2021 Feb 10, 2022	BUY	$2.7 - $4.76 $13,213 - $23,295	4,894 Added 4.53%	112,877 $306,000
Q3 2021 Nov 12, 2021	BUY	$4.06 - $5.8 $9,788 - $13,983	2,411 Added 2.28%	107,983 $482,000
Q2 2021 Aug 05, 2021	BUY	$5.02 - $7.05 $20,300 - $28,510	4,044 Added 3.98%	105,572 $612,000
Q1 2021 May 06, 2021	SELL	$4.81 - $10.34 $28,417 - $61,088	-5,908 Reduced 5.5%	101,528 $713,000
Q4 2020 Feb 10, 2021	BUY	$4.13 - $6.41 $36,984 - $57,401	8,955 Added 9.09%	107,436 $516,000
Q3 2020 Nov 12, 2020	SELL	$4.82 - $7.72 $84,913 - $136,003	-17,617 Reduced 15.17%	98,481 $574,000
Q2 2020 Aug 13, 2020	BUY	$5.69 - $9.69 $281,677 - $479,693	49,504 Added 74.34%	116,098 $784,000
Q1 2020 May 06, 2020	SELL	$3.77 - $11.0 $731 - $2,134	-194 Reduced 0.29%	66,594 $424,000
Q4 2019 Feb 05, 2020	BUY	$3.0 - $16.43 $915 - $5,011	305 Added 0.46%	66,788 $696,000
Q3 2019 Oct 23, 2019	SELL	$3.93 - $15.35 $314 - $1,228	-80 Reduced 0.12%	66,483 $261,000
Q2 2019 Aug 14, 2019	BUY	$12.81 - $25.67 $42,093 - $84,351	3,286 Added 5.19%	66,563 $990,000
Q1 2019 May 01, 2019	SELL	$17.66 - $30.28 $12,097 - $20,741	-685 Reduced 1.07%	63,277 $1.57 Million
Q4 2018 Jan 31, 2019	BUY	$11.63 - $32.67 $230,739 - $648,172	19,840 Added 44.97%	63,962 $1.15 Million
Q3 2018 Nov 07, 2018	SELL	$29.37 - $49.48 $101,737 - $171,398	-3,464 Reduced 7.28%	44,122 $1.3 Million
Q2 2018 Aug 06, 2018	BUY	$42.06 - $62.4 $172,866 - $256,464	4,110 Added 9.45%	47,586 $2.16 Million
Q1 2018 May 02, 2018	SELL	$50.12 - $67.72 $56,585 - $76,455	-1,129 Reduced 2.53%	43,476 $2.3 Million
Q4 2017 Feb 09, 2018	SELL	$57.69 - $84.58 $525,209 - $770,016	-9,104 Reduced 16.95%	44,605 $3.03 Million
Q3 2017 Nov 06, 2017	BUY	$67.17 - $84.81 $3.61 Million - $4.56 Million	53,709	53,709 $4.43 Million

Others Institutions Holding CLVS

# of Institutions

Shares Held

166

Call Options Held

Put Options Held

Exane Derivatives

166
Shares

$14
0.0% of portfolio

View Full List

About Clovis Oncology, Inc.

Ticker CLVS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 144,480,000
Market Cap $13M
Description
Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...

More about CLVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account